COVID-19 vaccines

Vaccination

Alternative Vaccination Strategies Show Promise for Transplant Recipients with Impaired Immune Response

Accumulating evidence has shown that solid organ transplant recipients have a significantly impaired responsiveness to standard SARS-CoV-2 mRNA-based vaccination, highlighting the need for alternative strategies to protect this vulnerable group. Researchers have been exploring different vaccination approaches, including the administration of a third dose of either heterologous ChAdOx1 (AstraZeneca) or